21 March, 2022

A new opinion from the Commission for Access to Administrative Documents (CADA) grants PAGE ONE the right to know raw data on the adverse reactions of covid-19 vaccines and the use of remdesivir, the controversial antiviral used in patients-covid, advised against by the World Health Organization but “sponsored” by experts with links to the pharmaceutical company Gilead. Infarmed did not want to give access, claiming that this information is not intended for “public knowledge” and that there may be “social alarm.”